They are well-tolerated for long-term use and are particularly useful for patients on GLP-1 medications
Beyond gaining FDA approval, the other challenge is making sure people with type 1 diabetes have the right information to make informed decisions and take charge of their own diabetes management
, There is no evidence of increased familial incidence
Mounjaro News & Lawsuit Updates Prior to 2025 December 2, 2024: Number of Mounjaro and GLP-1 Lawsuits Grows to 1,300 in December As of December 2, 2024, 1,300 people have alleged injuries from Mounjaro and other GLP-1 drugs and filed lawsuits as part of multidistrict litigation
Without a healthcare provider to guide the process, people often take incorrect doses or skip the necessary gradual titration, which can result in severe gastrointestinal issues and, in some cases, hospitalizations
Respondents were included as having diabetes if they stated that they had ever been told by a doctor or other health professional that they had type 2 diabetes or did not know their specific type of diabetes (those with type 1 diabetes and other type of diabetes were excluded)
